Proto-Oncogene Proteins c-bcr [protoonkogenní proteiny c-bcr]
- Terms
-
proteiny c-bcr
protoonkogenní proteiny bcr
-
bcr Proto-Oncogene Proteins
Breakpoint Cluster Region Protein
c-bcr Proteins
c-bcr Proto-Oncogene Proteins
Proto-Oncogene Protein bcr
Proto-Oncogene Protein c-bcr
A serine-threonine kinase that contains a C2 DOMAIN and PLECKSTRIN HOMOLOGY DOMAIN. It also has activity as a GTPASE-ACTIVATING PROTEIN for RAC1 PROTEIN and CDC42 PROTEIN. It functions as a negative regulator of CELL PROLIFERATION and NEOPLASTIC CELL TRANSFORMATION and is commonly fused with cellular abl protein to form BCR-ABL FUSION PROTEINS in PHILADELPHIA CHROMOSOME positive LEUKEMIA patients.
- DUI
- D051562 MeSH Browser
- CUI
- M0155533
- History note
- 2006(1988)
- Public note
- 2006; PROTO-ONCOGENE PROTEIN C-BCR was indexed under PROTEIN-TYROSINE KINASE & PROTO-ONCOGENE PROTEINS 1988-2005
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 3
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 1
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 5
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 2
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 1
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 2
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0